Dr Reddy's launches generic acid reflux drug in US

The company has launched the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg after the approval from the USFDA, Dr Reddy's Laboratories said in a filing to the BSE.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news